BGI is a reliable outsourcing partner for the biopharmaceutical industry, providing a wide array of high quality and regulatory-compliant services for pharmacogenomics research, including:
– Next Generation Sequencing services including: RNA-Seq, Whole Genome Sequencing, Exome Sequencing, and Targeted Resequencing
– Tumor Profiling
– Epigenomics Services (CHiPseq, BiSulfite Sequencing, MeDiP)
– SNP, mutation and biomarker analysis
Our experience in high-capacity, high- throughput analytics, bioinformatics capabilities, and our long history in large population–scale genomics and data analysis, means that BGI is uniquely positioned to support pharmaceutical companies throughout the drug development and production process, from the preclinical phase through to clinical trials phases.
We enable our partners to develop effective and safe drugs more efficiently and economically.
To learn more about our services or for a customized solution for your project needs, please don’t hesitate to contact us at firstname.lastname@example.org.